title: [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)].
abstract: From October 2001 to September 2002, we collected the specimen from 370 patients with lower respiratory tract infections in 16 institutions in Japan, and investigated the susceptibilities of the isolated bacteria to various antibacterial agents and antibiotics and patients' characteristics. Of 458 strains that were isolated from specimen (mainly from sputum) and assumed to be bacteria causing in inflammation, 456 strains were investigated. The breakdown of the isolated bacteria were: Staphylococcus aureus 69, Streptococcus pneumoniae 72, Haemophilus influenzae 85, Pseudomonas aeruginosa (non-mucoid) 44, P. aeruginosa (mucoid) 13, Klebsiella pneumoniae 32, Moraxella subgenus Branhamella catarrhalis 32, and others. Of 69 S. aureus strains, those with 4 micrograms/mL or more of MIC of oxacillin (methicillin-resistant S. aureus: MRSA) occupied 43.5%. Vancomycin and arbekacin showed the most potent activities against MRSA as observed in 2000. The frequency of S. pneumoniae exhibiting low sensitivity to penicillin (penicillin-intermediate S. pneumoniae: PISP + penicillin-resistant S. pneumoniae: PRSP) was 59.7% and both rates of PISP and PRSP were the highest after 1992. Carbapenems had strong activities against S. pneumoniae. Especially, panipenem and imipenem inhibited the growth of all 72 strains at 0.125 and 0.5 microgram/mL, respectively. Generally, all drugs had strong activities against H. influenzae with MIC90s of 16 micrograms/mL or less. The drug that had the strongest activity against H. influenzae was levofloxacin, which inhibited the growth of 80 of the 85 strains at 0.063 microgram/mL. Against P. aeruginosa mucoid strain, meropenem had a strong activity with MIC90 of 0.5 microgram/mL while, against non-mucoid strain, tobramycin had a strong activity with MIC90 of 2 micrograms/mL. K. pneumoniae showed good susceptibilities to all drugs except ampicillin and minocycline, and the MIC90s were 4 micrograms/mL or less. Particularly, cefmenoxime, cefpirome, and imipenem had the strongest activity (MIC90: 0.125 microgram/mL), and cefozopran had a strong activity, inhibiting the growth of all strains at 0.25 microgram/mL. Also, all drugs generally had strong activities against M. (B.) catarrhalis. MIC90s of all drugs were 4 micrograms/mL or less. The drug that had the strongest activity was minocycline and levofloxacin inhibiting all 32 strains at 0.063 microgram/mL. Most of the patients with respiratory infection were aged 70 years or older, accounting for approximately a half of the total (40.5%). As for the incidence by the diseases, bacterial pneumonia and chronic bronchitis were the highest, being noted in 39.2% and 37.3% of all the patients, respectively. The bacteria frequently isolated from the patients with bacterial pneumonia were S. aureus (19.3%) and S. pneumoniae (19.9%). In contrast, H. influenzae (22.0%) were frequently isolated from the patients with chronic bronchitis. Before the drug administration, the bacteria frequently isolated from the patients were S. pneumoniae (20.8%) and H. influenzae (21.5%). S. pneumoniae and H. influenzae decreased after the initiation of drug administration while S. aureus increased. The isolation frequency of P. aeruginosa was higher after than before the initiation of drug administration. The bacteria were frequently isolated from the patients who had already treated with cephems were S. aureus and P. aeruginosa. From the patients who had already treated with macrolides, S. pneumoniae was the most frequently isolated while S. aureus was the most frequently isolated from the patients pre-treated with quinolones.
authors.affiliation: Tokyo Senbai Hospital.
authors.forename: Kaoru
authors.initials: K
authors.lastname: Shimada
authors.forename: Toyoko
authors.initials: T
authors.lastname: Oguri
authors.forename: Jun
authors.initials: J
authors.lastname: Igari
authors.forename: Hideo
authors.initials: H
authors.lastname: Ikemoto
authors.forename: Takeshi
authors.initials: T
authors.lastname: Mori
authors.forename: Nobuko
authors.initials: N
authors.lastname: Kitamura
authors.forename: Kunio
authors.initials: K
authors.lastname: Nakano
authors.forename: Yasutoshi
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yokouchi
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Karasawa
authors.forename: Tsugio
authors.initials: T
authors.lastname: Terai
authors.forename: Makoto
authors.initials: M
authors.lastname: Yamamoto
authors.forename: Kouichiro
authors.initials: K
authors.lastname: Nakata
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Nakatani
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Inoue
authors.forename: Toshihide
authors.initials: T
authors.lastname: Nakadate
authors.forename: Hiroko
authors.initials: H
authors.lastname: Inagawa
authors.forename: Akira
authors.initials: A
authors.lastname: Suwabe
authors.forename: Ritsuko
authors.initials: R
authors.lastname: Obata
authors.forename: Kouichiro
authors.initials: K
authors.lastname: Kudo
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Kobayashi
authors.forename: Isao
authors.initials: I
authors.lastname: Ohno
authors.forename: Shinji
authors.initials: S
authors.lastname: Okada
authors.forename: Katsutoshi
authors.initials: K
authors.lastname: Hayashi
authors.forename: Tadao
authors.initials: T
authors.lastname: Kinoshita
authors.forename: Hisami
authors.initials: H
authors.lastname: Konosaki
authors.forename: Masaaki
authors.initials: M
authors.lastname: Arakawa
authors.forename: Fumitake
authors.initials: F
authors.lastname: Gejyo
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kobayashi
authors.forename: Hajime
authors.initials: H
authors.lastname: Goto
authors.forename: Kenichi
authors.initials: K
authors.lastname: Igarashi
authors.forename: Shin
authors.initials: S
authors.lastname: Kawai
authors.forename: Masahiko
authors.initials: M
authors.lastname: Okada
authors.forename: Akira
authors.initials: A
authors.lastname: Ito
authors.forename: Midori
authors.initials: M
authors.lastname: Sumitomo
authors.forename: Nobuki
authors.initials: N
authors.lastname: Aoki
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Matsushima
authors.forename: Yoshihito
authors.initials: Y
authors.lastname: Niki
authors.forename: Moritaka
authors.initials: M
authors.lastname: Suga
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Hirakata
authors.forename: Shiho
authors.initials: S
authors.lastname: Aoki
authors.forename: Junichi
authors.initials: J
authors.lastname: Matsuda
authors.forename: Masakazu
authors.initials: M
authors.lastname: Tosaka
authors.forename: Masaru
authors.initials: M
authors.lastname: Nasu
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nagai
authors.forename: Shigeru
authors.initials: S
authors.lastname: Kohno
authors.forename: Kazunori
authors.initials: K
authors.lastname: Tomono
authors.forename: Yoshitsugu
authors.initials: Y
authors.lastname: Miyazaki
authors.forename: Kazufumi
authors.initials: K
authors.lastname: Hiramatsu
authors.forename: Tadao
authors.initials: T
authors.lastname: Nakano
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D024881:Drug Resistance, Bacterial; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000453:epidemiology / Q000382:microbiology*; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents